MR-3

MR-3 is a triple-agonist compound that has shown notable results in clinical studies. Individual outcomes vary significantly. Your provider will evaluate whether this compound is appropriate for your specific medical situation based on your history and current treatment plan.

Any changes to current medications, including transitioning between GLP-1 or related compounds, must be evaluated and directed by your licensed healthcare provider based on your individual medical history and current treatment plan.

• Triple agonist (GLP-1 / GIP / Glucagon)
• Next-generation weight loss peptide currently under clinical investigation
• May have a different side effect profile compared to other medications (discuss with your provider)
• Promotes more effective fat loss

Disclaimer:
MR-3 is an investigational medication and is not currently approved by the U.S. Food and Drug Administration (FDA) for general clinical use in obesity, diabetes, or any other indication outside of clinical trials. Information about MR-3 potential benefits, risks, and dosing is based on ongoing and completed clinical trials and may change as additional data become available.
Any discussion of MR-3 here is for educational purposes only and should not be interpreted as a treatment recommendation or as a substitute for professional medical advice, diagnosis, or care from a qualified healthcare provider. Patients should not seek, start, or adjust any medication regimen involving MR-3 outside of approved research settings or without direct guidance from a licensed clinician familiar with the most current evidence and regulatory status.
Defy Age RX does not dispense medication; no product is provided without a valid prescription. Individual results vary. Not medical advice.